GlassScriptPhysician profile
Stephen Kayiaros
NPI 1669699542
$30,644.52
in general payments reported to CMS, 2019-2025
15 companies · $4,036 in 2025
The $4,036 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,525 · 2021: $851 · 2022: $511 · 2023: $615 · 2024: $11K · 2025: $4,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $1,769 · Travel and Lodging: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,936.00 |
| Food and Beverage | $1,768.83 |
| Travel and Lodging | $763.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $11,722.70 | 2020-2025 | Icona Stem (Fka Abc Stem), Corin Hips, Omnibotics 3.0 |
| Depuy Synthes Products, INC. | $5,904.02 | 2019 | |
| Medical Device Business Services, INC. | $4,976.12 | 2024-2025 | Attune, Reclaim, Actis |
| Corin USA | $4,957.39 | 2019 | |
| Stryker Corporation | $1,000.94 | 2019-2025 | Gamma |
| Depuy Synthes Sales INC. | $732.87 | 2019-2025 | Attune, Velys, Inhance |
| Zimmer Biomet Holdings, INC. | $602.19 | 2019-2025 | Persona |
| Avanos Medical | $243.29 | 2020-2025 | On-Q* Pump and Accessories, On-Q Pump and Accessories |
| Abbott Laboratories | $157.25 | 2024 | Proclaim |
| Biocomposites INC | $106.62 | 2024 | |
| Kci USA, INC. | $97.42 | 2020 | |
| Nextstep Arthropedix, LLC | $87.43 | 2021 | |
| Nevro Corp. | $20.46 | 2020 | |
| Baudax Bio INC. | $18.97 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kayiaros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.